Month: May 2015

Archer Daniels Midland Company ADM began 2015 on a mixed note, reporting spectacular bottom-line results despite the top line lagging expectations. The company’s adjusted earnings for the first quarter of 2015 surged 40% year over year to 77 cents per share, cruising much ahead of the Zacks Consensus Estimate of 71 cents. On a reported basis, Archer Daniels’ earnings soared a whopping 92.5% from the year-ago quarter […]

Harris Corporation HRS delivered mixed numbers in the third quarter of fiscal 2015 (ended Apr 3, 2015) reporting better-than-expected earnings but lower-than-estimated revenues. The company’s earnings (on an adjusted basis) of $1.32 per share breezed past the Zacks Consensus Estimate of $1.23. Quarterly earnings were 3.9% above the year-ago figure […]

Noble Energy, Inc. NBL reported adjusted earnings of 3 cents per share in the first quarter of 2015, in line with the Zacks Consensus Estimate. However, quarterly earnings slumped 96.3% from the prior-year figure due to a significant decline in commodity prices […]

Anadarko Petroleum Corporation APC reported a first-quarter 2015 adjusted loss of 72 cents per share, wider than the Zacks Consensus Estimate of a loss of 63 cents. This amounted to a negative earnings surprise of 14.29%. […]

Emerson Electric Company EMR reported second-quarter fiscal 2015 adjusted earnings per share of 65 cents per share, which fell short of the Zacks Consensus Estimate of 76 cents and came below the year-ago quarter figure of 77 cents. Emerson Electric Company – Earnings Surprise | FindTheCompany A strong cut in spending by global customers in oil and gas and industrial markets and strengthening of the U.S. dollar acted as the headwinds. […]

Mallinckrodt plc MNK reported adjusted earnings of $1.72 per share in the second quarter of fiscal 2015 (ended Mar 27, 2015), beating the Zacks Consensus Estimate of $1.48. Earnings also exceeded the year-ago figure of 95 cents per share. […]

Radiation oncology company, Accuray Inc. ARAY , reported a loss of 4 cents per share in the third quarter of fiscal 2015. This was narrower than the Zacks Consensus Estimate of a loss of 5 cents and the year-ago loss of 6 cents per share. […]

Leading global car rental company, Avis Budget Group Inc. CAR reported first-quarter 2015 adjusted earnings per share of 17 cents, which grew 6.3% from the prior-year earnings and surpassed the Zacks Consensus Estimate of 14 cents. The upside came despite volatile global economic conditions, coupled with the industry-wide scenario of over-fleeting in North America […]

Armstrong World Industries, Inc. AWI reported a 14% year-over-year drop in its first-quarter fiscal 2015 earnings to 37 cents per share, falling short of the Zacks Consensus Estimate of 40 cents. Including one-time items, earnings nosedived 79% to 7 cents per share from the prior-year quarter figure of 33 cents. […]

Trimble Navigation ’s TRMB first-quarter 2015 earnings of 24 cents missed the Zacks Consensus Estimate by 2 cents. The quarter was impacted by broad-based weakness in the majority of Trimble’s businesses. […]

InvenSense, Inc. INVN reported fourth-quarter of fiscal 2015 earnings per share of 4 cents which came in line with the Zacks Consensus Estimate. Revenues The company reported revenues of $99.3 million, down 14.3% sequentially but up 68.3% year over year […]

NuVasive, Inc. NUVA reported first-quarter 2015 adjusted earnings per share (EPS) of 30 cents, reflecting a substantial 66.7% rise from the year-ago quarter and a 42.8% beat over the Zacks Consensus Estimate. […]

Leading pet pharmacy in the Americas, PetMed Express PETS , reported earnings per share (EPS) of 25 cents in the fourth quarter of fiscal 2015, up 8.7% year over year. The number also exceeded the Zacks Consensus Estimate by a penny. For fiscal 2015, excluding a one-time charge for an IT-related discontinued project, adjusted EPS came in at 92 cents, 2 cents ahead of the year-ago number […]

Keryx Biopharmaceuticals KERX reported a loss of 28 cents per share in the first quarter of 2015, in line with the Zacks Consensus Estimate. The year-ago quarter figure was a loss of 15 cents. Keryx Biopharmaceuticals Inc […]